Calvert Investment Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-62,670
Closed -$4.61M 340
2016
Q4
$4.61M Sell
62,670
-612
-1% -$45.6K 0.17% 172
2016
Q3
$5.08M Buy
63,282
+3,525
+6% +$282K 0.19% 164
2016
Q2
$4.71M Buy
59,757
+2,341
+4% +$176K 0.19% 135
2016
Q1
$4.13M Buy
57,416
+5,909
+11% +$447K 0.18% 110
2015
Q4
$4.34M Buy
51,507
+10,005
+24% +$830K 0.2% 99
2015
Q3
$3.47M Sell
41,502
-792
-2% -$66.9K 0.17% 122
2015
Q2
$3.53M Sell
42,294
-1,509
-3% -$115K 0.16% 125
2015
Q1
$3.18M Buy
43,803
+4,795
+12% +$341K 0.21% 123
2014
Q4
$2.69M Buy
39,008
+2,936
+8% +$198K 0.18% 132
2014
Q3
$2.34M Buy
36,072
+26,627
+282% +$1.69M 0.17% 137
2014
Q2
$587K Sell
9,445
-112
-1% -$6.68K 0.04% 221
2014
Q1
$563K Buy
9,557
+27
+0.3% +$1.51K 0.04% 214
2013
Q4
$486K Hold
9,530
0.04% 228
2013
Q3
$480K Buy
+9,530
New +$499K 0.06% 219

Other funds holding LLY

Calvert Investment Management's LLY Position: Q1 2017 in Review

Calvert Investment Management sold out of Eli Lilly (LLY) in Q1 2017, closing a stake of 62,670 shares — an estimated $4.61M sold.

Calvert Investment Management first reported a position in LLY in Q3 2013 and held it in 14 quarters. The position peaked at $5.08M in Q3 2016. 1,249 funds tracked by Wall St. Rank hold LLY as of Q1 2017.

  • Calvert Investment Management reported no remaining Eli Lilly position as of Q1 2017 after selling out during the quarter.
  • Calvert Investment Management sold 62,670 Eli Lilly shares in Q1 2017, an estimated $4.61M.
  • Calvert Investment Management first reported a position in Eli Lilly in Q3 2013 and held it in 14 quarters.
  • Calvert Investment Management's Eli Lilly position peaked at $5.08M in Q3 2016.
  • 1,249 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2017.

Based on Calvert Investment Management's 13F filing for Q1 2017.